Lyra paus­es work on si­nusi­tis drug; Pathos AI li­cens­es a new as­set

Plus, news about Con­ver­gent Ther­a­peu­tics, Turn­stone Bi­o­log­ics and Son­net Bio­Ther­a­peu­tics:

Lyra Ther­a­peu­tics paus­es de­vel­op­ment of chron­ic rhi­nos­i­nusi­tis drug: The com­pa­ny

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER